Imiglucerase
- Generic Name
- Imiglucerase
- Brand Names
- Cerezyme
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 154248-97-2
- Unique Ingredient Identifier
- Q6U6J48BWY
- Background
Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD. Alglucerase is prepared by modification of the oligosaccharide chains of human Beta-glucocerebrosidase. The modification alters the sugar residues at the non-reducing ends of the oligosaccharide chains ...
- Indication
For the treatment of Gaucher's disease (deficiency in glucocerebrosidase)
- Associated Conditions
- Gaucher Disease, Type 1, Gaucher Disease, Type III
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath